Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Appointed director
Quarterly results

ACELRX PHARMACEUTICALS INC (ACRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/25/2023 4 Palmer Pamela P (Chief Medical Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Sold 9,514 shares @ $1.17, valued at $11.1k
Sold 7,442 shares @ $1.089, valued at $8.1k
03/06/2023 4 Dasu Badri N (Chief Engineering Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 398 shares @ $1.31, valued at $521.4
03/06/2023 4 Palmer Pamela P (Chief Medical Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 570 shares @ $1.31, valued at $746.7
03/06/2023 4 ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 510 shares @ $1.31, valued at $668.1
03/06/2023 4 Angotti Vincent J. (CEO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,703 shares @ $1.31, valued at $2.2k
02/08/2023 4 Dasu Badri N (Chief Engineering Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 458 shares @ $2.02, valued at $925.2
02/08/2023 4 ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 617 shares @ $2.02, valued at $1.2k
02/08/2023 4 Palmer Pamela P (Chief Medical Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 681 shares @ $2.02, valued at $1.4k
02/08/2023 4 Angotti Vincent J. (CEO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,982 shares @ $2.02, valued at $4k
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2022 4 Afable Richard (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Granted 15,500 shares @ $0
Granted 31,000 options to buy @ $0.2309, valued at $7.2k
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/15/2022 4 Rosen Howard B (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Granted 15,500 shares @ $0
Granted 31,000 options to buy @ $0.2309, valued at $7.2k
07/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2022 4 Angotti Vincent J. (CEO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Bought 46,400 shares @ $0.2227, valued at $10.3k
03/04/2022 4 Palmer Pamela P (Chief Medical Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 7,923 shares @ $0.4068, valued at $3.2k
03/04/2022 4 Dasu Badri N (Chief Engineering Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 5,612 shares @ $0.4068, valued at $2.3k
03/04/2022 4 ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 7,923 shares @ $0.4068, valued at $3.2k
03/04/2022 4 Angotti Vincent J. (CEO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 23,051 shares @ $0.4068, valued at $9.4k
02/14/2022 4 Palmer Pamela P (Chief Medical Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Granted 122,500 shares @ $0
Paid exercise price by delivering 7,927 shares @ $0.4014, valued at $3.2k
Granted 245,000 options to buy @ $0.4014, valued at $98.3k
02/14/2022 4 Dasu Badri N (Chief Engineering Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Granted 97,500 shares @ $0
Paid exercise price by delivering 5,615 shares @ $0.4014, valued at $2.3k
Granted 195,000 options to buy @ $0.4014, valued at $78.3k
02/14/2022 4 ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Granted 117,500 shares @ $0
Paid exercise price by delivering 7,927 shares @ $0.4014, valued at $3.2k
Granted 235,000 options to buy @ $0.4014, valued at $94.3k
02/14/2022 4 Angotti Vincent J. (CEO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Granted 390,000 shares @ $0
Paid exercise price by delivering 23,058 shares @ $0.4014, valued at $9.3k
Granted 780,000 options to buy @ $0.4014, valued at $313.1k
02/07/2022 4 Palmer Pamela P (Chief Medical Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 9,391 shares @ $0.4312, valued at $4k
02/07/2022 4 Dasu Badri N (Chief Engineering Officer) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 6,830 shares @ $0.4312, valued at $2.9k
02/07/2022 4 ASADORIAN RAFFI (CFO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 9,391 shares @ $0.4312, valued at $4k
02/07/2022 4 Angotti Vincent J. (CEO) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 27,318 shares @ $0.4312, valued at $11.8k
11/23/2021 4 Broadfoot Jill Marie (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Granted 15,000 shares @ $0
Granted 30,000 options to buy @ $0.72, valued at $21.6k
11/23/2021 3 Broadfoot Jill Marie (Director) has filed a Form 3 on ACELRX PHARMACEUTICALS INC
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/17/2021 4 Rosen Howard B (Director) has filed a Form 4 on ACELRX PHARMACEUTICALS INC
Txns: Granted 10,000 shares @ $0
Granted 20,000 options to buy @ $1.41, valued at $28.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy